本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

99.13
+0.13000.13%
盤前99.990.8600+0.87%07:57 EDT
成交量:186.57萬
成交額:1.86億
市值:196.45億
市盈率:-16.66
高:100.51
開:98.12
低:97.10
收:99.00
52周最高:124.49
52周最低:29.17
股本:1.98億
流通股本:1.79億
量比:0.97
換手率:1.04%
股息:- -
股息率:- -
每股收益(TTM):-5.9500
每股收益(LYR):-5.9502
淨資產收益率:-58.07%
總資產收益率:-30.08%
市淨率:12.04
市盈率(LYR):-16.66

資料載入中...

2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities